Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Viventia's Cancer Ambitions Go To Eleven

Sep 21 2016

• By Joseph Haas

US dollars and pills

Related Content

Eleven Biotherapeutics Shifts Focus After Trial Failure

May 18 2015

Biotech IPO Window Closed In November As Returns And Prices Plunged

Dec 03 2015

Does Deal With Roche Signal Eleven's Doomed Fate?

Jun 13 2016

Related Companies

Sesen Bio, Inc.

Roche Holding AG

Additional Topics

Deals M & A Commercial Cancer BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.